| 中文名 | 盐酸恩诺沙星 |
| 英文名 | ENROFLOXAIN HYDROCHLORIDE |
| 别名 | 盐酸恩诺沙星 恩诺沙星单盐酸盐 |
| 英文别名 | ENROFLOXAIN HYDROCHLORIDE 3-ic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-, Monohydrochloride (9CI) |
| CAS | 93106-59-3 |
| EINECS | 274-614-4 |
| 化学式 | C19H23ClFN3O3 |
| 分子量 | 395.8556232 |
| 体外研究 | Mycoplasma bovis is a worldwide pathogen, causative agent of pneumonia, mastitis, arthritis, and a variety of other symptoms in cattle. The antibiotic susceptibility profiles of the Hungarian strains are consistent within the tested group of fluoro Three isolates (MYC44, MYC45 and MYC46) have high MIC values (≥10 μg/mL) to Enrofloxacin, while the rest of the strains are inhibited by Enrofloxacin with MICs ≤0.312 or 0.625 μg/mL. |
| 体内研究 | Mice (n=80) undergo transient middle cerebral artery occlusion (MCAo) with reperfusion after 60 minutes. After MCAo, animals are randomly assigned to receive either a daily preventive medication (n=26, Enrofloxacin) starting at the day of MCAo or a therapeutic medication (n=25; Enrofloxacin) after diagnosis of lung infection. Standard treatment started immediately after the appearance of clinical signs (general health score>6) usually between day 4 and 6 after stroke. Both, preventive and standard antibiotic treatment using Enrofloxacin improve survival in a similar way compared with placebo treatment. |
| 成立日期 | 2022年03月08日 | ||
| 法定代表人 | ALLEN | ||
| 注册资本 | 50 | ||
| 主营产品 | 司美格鲁肽，阿法诺肽，索玛鲁肽，磷酸奥司他韦（兽用20%），特布他林 99.5％ ，奥洛他定 99.6％，萘必洛尔，替尔泊肽Tirzepatide2023788-19-2，索马鲁肽 Sermaglutide910463-68-2，瑞他肽Retatrutide2381089-83-2，布美诺肽PT-141 189691-06-3 | ||
| 经营范围 | 一般项目：专用化学产品制造（不含危险化学品）；化工产品销售（不含许可类化工产品）；专用化学产品销售（不含危险化学品）；生物化工产品技术研发；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；新型催化材料及助剂销售；新材料技术研发；货物进出口；技术进出口；医学研究和试验发展；塑料制品销售；互联网销售（除销售需要许可的商品）；化工产品生产（不含许可类化工产品）。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动） | ||
| 公司简介 | 重庆至夏化工有限公司成立于2023年，是一家从事化工原料研发、生产和销售的公司。公司位于中国西南地区的重庆市，拥有先进的生产设备和的技术团队。至夏分公司在过去的十几年研发里，公司始终秉承着“质量、信誉至上”的经营理念，不断创新和提高产品质量，赢得了广大客户的信任和支持。ChongqingZhixiaChemicalCo.,Ltd.wasestablishedin2023andisaprofessi ... | ||
